Form 4 for AMZN Amazon
Accepted 2025-05-23 17:35:15 ET · period of report 2025-05-21 · accession 0001018724-25-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-05-23 17:35 | 2025-05-21 | AMZN | Olsavsky Brian T | SVP, CFO | M - OptEx | $0.00 | +17.8K | 66.8K | +36% | $0 |
| DT | 2025-05-23 17:35 | 2025-05-21 | AMZN | Olsavsky Brian T | SVP, CFO | S - Sale+OE | $201.57 | -17.8K | 49.0K | -27% | -$3.58M |
| DMT | 2025-05-23 17:35 | 2025-05-21 | AMZN | Olsavsky Brian T | SVP, CFO | M - OptEx | $0.00 | -17.8K | 134.6K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $.01 per share | 2025-05-21 | M | A | 8,760 | $0.00 | 57,760 | D | — | — | |
| 2 | Common | Common Stock, par value $.01 per share | 2025-05-21 | M | A | 3,940 | $0.00 | 61,700 | D | — | — | |
| 3 | Common | Common Stock, par value $.01 per share | 2025-05-21 | M | A | 5,050 | $0.00 | 66,750 | D | — | — | |
| 4 | Common | Common Stock, par value $.01 per share | 2025-05-21 | S | D | 17,750 | $201.57 | 49,000 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/11/2024. |
| 5 | Derivative | Restricted Stock Unit Award | 2025-05-21 | M | D | 8,760 | $0.00 | 26,300 | D | $0.00 · 2022-05-21 to 2026-02-21 | 8,760 Common Stock, par value $.01 per share | (F2) Converts into Common Stock on a one-for-one basis. (F3) This award vests based upon the following vesting schedule: 2,960 shares on each of May 21, 2022, August 21, 2022, and November 21, 2022; 2,980 shares on February 21, 2023; 3,940 shares on each of May 21, 2023, August 21, 2023, November 21, 2023, and February 21, 2024; 11,360 shares on each of May 21, 2024, August 21, 2024, and November 21, 2024; 11,380 shares on February 21, 2025; 8,760 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; and 8,780 shares on February 21, 2026. |
| 6 | Derivative | Restricted Stock Unit Award | 2025-05-21 | M | D | 3,940 | $0.00 | 81,920 | D | $0.00 · 2023-05-21 to 2028-02-21 | 3,940 Common Stock, par value $.01 per share | (F2) Converts into Common Stock on a one-for-one basis. (F4) This award vests based upon the following vesting schedule: 2,260 shares on May 21, 2023; 2,240 shares on each of August 21, 2023, November 21, 2023, and February 21, 2024; 3,240 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,940 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 3,920 shares on February 21, 2026; 9,920 shares on May 21, 2026; 9,900 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,640 shares on May 21, 2027; and 7,620 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. |
| 7 | Derivative | Restricted Stock Unit Award | 2025-05-21 | M | D | 5,050 | $0.00 | 134,615 | D | $0.00 · 2025-05-21 to 2030-02-21 | 5,050 Common Stock, par value $.01 per share | (F2) Converts into Common Stock on a one-for-one basis. (F5) This award vests based upon the following vesting schedule: 5,050 shares on each of May 21, 2025, August 21, 2025, and November 21, 2025; 5,049 shares on February 21, 2026; 5,530 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,529 shares on February 21, 2027; 5,797 shares on each of May 21, 2027 and August 21, 2027; 5,796 shares on each of November 21, 2027 and February 21, 2028; 10,474 shares on each of May 21, 2028, August 21, 2028, and November 21, 2028; 10,473 shares on February 21, 2029; 8,067 shares on each of May 21, 2029 and August 21, 2029; and 8,066 shares on each of November 21, 2029 and February 21, 2030. |